Blind docking of 4-Amino-7-Chloroquinoline analogs as potential dengue virus protease inhibitor using CB Dock a web server-Supplemenntary data
Indian J Biochem Biophys
;
2023 Jan; 60(1): 55-57
Article
| IMSEAR
| ID: sea-221648
ABSTRACT
Currently, there is no approved drug to combat dengue. Various quinoline derivatives are known for potential antimalarial, antiviral activities, etc. In the present work docking between 4-Amino-7-Chloroquinoline analogs was performed with dengue virus NS2B/NS3 protease using CB dock, a web server. Lys74, Ile165, Val147, Asn152, Asn167, Trp83 and Leu149 amino acid residues were found to be in contact with designed 4-Amino-7-Chloroquinoline analogs. Different modes of binding like hydrogen bonding, hydrophobic interactions, etc with designed compounds improve potential anti-dengue characteristics in silico. ADME results are in acceptable range.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Journal:
Indian J Biochem Biophys
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS